Enhancement of antipsychotic-like properties of the dopamine D 2 receptor antagonist, raclopride, by the additional treatment with the 5-HT 2 receptor blocking agent, ritanserin, in the rat

By Wadenberg M.-L.   Salmi P.   Jimenez P.   Svensson T.   Ahlenius S.  

European Neuropsychopharmacology, Vol. 6, Iss. 4, 1996-11 ,pp. : 305-310

Elsevier

Access to resources Recommend Favorite

Effect of dopamine D2/D3 receptor antagonist sulpiride on amphetamine-induced changes in striatal extracellular dopamine

By Jaworski J.N.   Gonzales R.A.   Randall P.K.  

European Journal of Pharmacology, Vol. 418, Iss. 3, 2001-04 ,pp. : 201-206

Elsevier

Access to resources Recommend Favorite

Noradrenaline Reuptake Inhibition Enhances the Antipsychotic-like Effect of Raclopride and Potentiates D 2 -blockage-induced Dopamine Release in the Medial Prefrontal Cortex of the Rat

By Linner L.   Wiker C.   Wadenberg M.-L.   Schalling M.   Svensson T.H.  

Neuropsychopharmacology, Vol. 27, Iss. 5, 2002-11 ,pp. : 691-698

Elsevier

Access to resources Recommend Favorite

Potentiation of phencyclidine-induced dopamine release in the rat striatum by the blockade of dopamine D 2 receptor

By Yonezawa Y.   Kuroki T.   Tashiro N.   Hondo H.   Uchimura H.  

European Journal of Pharmacology, Vol. 285, Iss. 3, 1995-10 ,pp. : 305-308

Elsevier

Access to resources Recommend Favorite

Antagonism by the 5-HT 2A/C receptor agonist DOI of raclopride-induced catalepsy in the rat

By Wadenberg M.-L.   Ahlenius S.  

European Journal of Pharmacology, Vol. 294, Iss. 1, 1995-01 ,pp. : 247-251

Elsevier

Access to resources Recommend Favorite